European Journal of Cancer
Volume 37, Issue 14 , Pages 1746-1751, September 2001

Willingness-to-pay for colorectal cancer screening

  • E Frew

      Affiliations

    • Research Assistant, Trent Institute for Health Services Research, University of Nottingham, Nottingham, UK
  • ,
  • J.L Wolstenholme

      Affiliations

    • Research Fellow, Health Economics Research Centre, University of Oxford, Oxford, UK
  • ,
  • D.K Whynes

      Affiliations

    • Professor of Health Economics, School of Economics, University of Nottingham, Nottingham NR7 2RD, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-115-951-5463; fax: +44-115-951-4159

Received 24 April 2001; accepted 25 May 2001.

Abstract 

Willingness-to-pay (WTP) techniques are increasingly being used in economic evaluation, as a means of assessing the value of new health care technologies. This paper presents the results of a WTP investigation of two types of screening for colorectal cancer. A questionnaire was issued to a general population via general practitioners (GPs), yielding a sample of approximately 2000 cases for analysis. Regression models demonstrated that WTP was significantly influenced by factors such as gender, income, age, risk perceptions, illness experiences and health beliefs. The median WTP for screening emerged as being £30 or £50, depending on the method used to elicit WTP, but independent of the screening protocol. Combining the results with those from related research, it emerged, first, that WTP subjects offered higher values for flexible sigmoidoscopy screening than the costs actually incurred by revealed preference studies and, second, they offered WTP values similar to the likely resource costs of the screening procedures.

Keywords:  Colorectal cancer, Faecal occult blood test, Screening, Sigmoidoscopy, Willingness-to-pay

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(01)00200-3

European Journal of Cancer
Volume 37, Issue 14 , Pages 1746-1751, September 2001